Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases

Current Medicinal Chemistry

Volumn 16, Issue 12, 2009, Pages 1451-1462

  Jagtap, Smita ^a   Meganathan, Kesavan ^a   Wagh, Vilas ^a   Winkler, Johannes ^a   Hescheler, Jürgen ^a   Sachinidis, Agapios ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cancer; Cardiovascular diseases; Chemoprevention; Curcumin; Epigallocatechin 3 O gallate; Molecular mechanism; Quercetin

Indexed keywords

BISTETRAHYDROCURCUMIN; CISPLATIN; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; NATURAL PRODUCT; PIPERINE; POLYPHENOL DERIVATIVE; PROTEIN KINASE; QUERCETIN; SULINDAC; TETRAHYDROCURCUMIN; TUMERONE; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; APOPTOSIS; CANCER THERAPY; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; HEAD AND NECK CARCINOMA; HEART INFARCTION; HUMAN; INTESTINE TUMOR; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CATECHIN; CURCUMIN; HUMANS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NEOPLASMS; OXIDATIVE STRESS; QUERCETIN;

EID: 65649137735     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787909578     Document Type: Review

References (124)

1. Singletary, K. Diet, natural products and cancer chemoprevention. J. Nutr., 2000, 130, 465S-6S.
2. Di Carlo, G.; Mascolo, N.; Izzo, A.A.; Capasso, F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci., 1999, 65, 337-53.
3. Rao, C.V.; Rivenson, A.; Simi, B.; Reddy, B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 1995, 55, 259-66.
4. Gouni-Berthold, I.; Sachinidis, A. Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. Curr. Pharm. Des., 2004, 10, 1261-71.
5. Lin, J.K.; Chen, Y.C.; Huang, Y.T.; Lin-Shiau, S.Y. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J. Cell Biochem. Suppl, 1997, 28-29, 39-48.
6. Inano, H.; Onoda, M.; Inafuku, N.; Kubota, M.; Kamada, Y.; Osawa, T.; Kobayashi, H.; Wakabayashi, K. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis, 1999, 20, 1011-8.
7. Shishodia, S.; Sethi, G.; Aggarwal, B.B. Curcumin: Getting back to the roots. Ann. N. Y. Acad. Sci., 2005, 1056, 206-17.
8. Boone, C.W.; Kelloff, G.J.; Malone, W.E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res., 1990, 50, 2-9.
9. Kelloff, G.J.; Boone, C.W.; Malone, W.; Steele, V. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. Basic Life Sci., 1993, 61, 373-86.
10. Ammon, H.P.; Wahl, M.A. Pharmacology of Curcuma longa. Planta Med., 1991, 57, 1-7.
11. Nirmala, C.; Puvanakrishnan, R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell Biochem., 1996, 159, 85-93.
12. Huang, M.T.; Newmark, H.L.; Frenkel, K. Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl, 1997, 27, 26-34.
13. Garcea, G.; Berry, D.P.; Jones, D.J.; Singh, R.; Dennison, A.R.; Farmer, P.B.; Sharma, R.A.; Steward, W.P.; Gescher, A.J. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 120-5.
14. Long, L.H.; Clement, M.V.; Halliwell, B. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem. Biophys. Res. Commun., 2000, 273, 50-3.
15. Wilson, M.R. Apoptosis: Unmasking the executioner. Cell Death Differ., 1998, 5, 646-52.
16. Squires, M.S.; Hudson, E.A.; Howells, L.; Sale, S.; Houghton, C.E.; Jones, J.L.; Fox, L.H.; Dickens, M.; Prigent, S.A.; Manson, M.M. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol., 2003, 65, 361-76.
17. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm., 2007, 4, 807-18.
18. Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med., 1998, 64, 353-6.
19. Arts, I.C.; Jacobs, D.R., Jr.; Gross, M.; Harnack, L.J.; Folsom, A.R. Dietary catechins and cancer incidence among postmenopausal women: The Iowa Women's Health Study (United States). Cancer Causes Control, 2002, 13, 373-82.
20. Mukhtar, H.; Ahmad, N. Green tea in chemoprevention of cancer. Toxicol. Sci., 1999, 52, 111-7.
21. McKay, D.L.; Blumberg, J.B. The role of tea in human health: An update. J. Am. Coll. Nutr., 2002, 21, 1-13.
22. Liao, S.; Kao, Y.H.; Hiipakka, R.A. Green tea: Biochemical and biological basis for health benefits. Vitam. Horm., 2001, 62, 1-94.
23. Liao, S.; Umekita, Y.; Guo, J.; Kokontis, J.M.; Hiipakka, R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett., 1995, 96, 239-43.
24. Katiyar, S.K.; Mukhtar, H. Tea antioxidants in cancer chemoprevention. J. Cell Biochem. Suppl., 1997, 27, 59-67.
25. Suganuma, M.; Okabe, S.; Sueoka, N.; Sueoka, E.; Matsuyama, S.; Imai, K.; Nakachi, K.; Fujiki, H. Green tea and cancer chemoprevention. Mutat. Res., 1999, 428, 339-44.
26. Weber, A.A.; Neuhaus, T.; Skach, R.A.; Hescheler, J.; Ahn, H.Y.; Schror, K.; Ko, Y.; Sachinidis, A. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J., 2004, 18, 128-30.
27. Sachinidis, A.; Seul, C.; Seewald, S.; Ahn, H.; Ko, Y.; Vetter, H. Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett., 2000, 471, 51-5.
28. Pace-Asciak, C.R.; Hahn, S.; Diamandis, E.P.; Soleas, G.; Goldberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin. Chim. Acta, 1995, 235, 207-19.
29. Gross, M.; Pfeiffer, M.; Martini, M.; Campbell, D.; Slavin, J.; Potter, J. The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiol. Biomarkers Prev., 1996, 5, 711-20.
30. Duthie, S.J.; Johnson, W.; Dobson, V.L. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat. Res., 1997, 390, 141-51.
31. Yoshida, M.; Yamamoto, M.; Nikaido, T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res., 1992, 52, 6676-81.
32. Nishioka, H.; Imoto, M.; Sawa, T.; Hamada, M.; Naganawa, H.; Takeuchi, T.; Umezawa, K. Screening of phosphatidylinositol kinase inhibitors from Streptomyces. J. Antibiot. (Tokyo), 1989, 42, 823-5.
33. Russo, M.; Palumbo, R.; Tedesco, I.; Mazzarella, G.; Russo, P.; Iacomino, G.; Russo, G.L. Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett., 1999, 462, 322-8.
34. Lin, J.K.; Pan, M.H.; Lin-Shiau, S.Y. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors, 2000, 13, 153-8.
35. Kuo, M.L.; Huang, T.S.; Lin, J.K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta, 1996, 1317, 95-100.
36. Fujisawa, S.; Atsumi, T.; Ishihara, M.; Kadoma, Y. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res., 2004, 24, 563-9.
37. Scott, D.W.; Loo, G. Curcumin-induced GADD153 gene upregulation in human colon cancer cells. Carcinogenesis, 2004, 25, 2155-64.
38. Joe, B.; Vijaykumar, M.; Lokesh, B.R. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr., 2004, 44, 97-111.
39. Gupta, S.; Mukhtar, H. Chemoprevention of skin cancer through natural agents. Skin Pharmacol. Appl. Skin Physiol., 2001, 14, 373-85.
40. Piper, J.T.; Singhal, S.S.; Salameh, M.S.; Torman, R.T.; Awasthi, Y.C.; Awasthi, S. Mechanisms of anticarcinogenic properties of curcumin: The effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol., 1998, 30, 445-56.
41. Song, G.; Mao, Y.B.; Cai, Q.F.; Yao, L.M.; Ouyang, G.L.; Bao, S.D. Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz. J. Med. Biol. Res., 2005, 38, 1791-8.
42. Ushida, J.; Sugie, S.; Kawabata, K.; Pham, Q.V.; Tanaka, T.; Fujii, K.; Takeuchi, H.; Ito, Y.; Mori, H. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res., 2000, 91, 893-8.
43. Campbell, F.C.; Collett, G.P. Chemopreventive properties of curcumin. Future Oncol., 2005, 1, 405-14.
44. Manson, M.M.; Gescher, A.; Hudson, E.A.; Plummer, S.M.; Squires, M.S.; Prigent, S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett., 2000, 112-113, 499-505.
45. Cabrera, C.; Artacho, R.; Gimenez, R. Beneficial effects of green tea-a review. J. Am. Coll. Nutr., 2006, 25, 79-99.
46. Tosetti, F.; Ferrari, N.; De Flora, S.; Albini, A. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J., 2002, 16, 2-14.
47. Jung, Y.D.; Ellis, L.M. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int. J. Exp. Pathol., 2001, 82, 309-16.
48. Devika, P.T.; Stanely Mainzen, P.P. Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A histopathological study. Biomed. Pharmacother., 2008, 62(10), 701-8.
49. Unno, T.; Tago, M.; Suzuki, Y.; Nozawa, A.; Sagesaka, Y.M.; Kakuda, T.; Egawa, K.; Kondo, K. Effect of tea catechins on post-prandial plasma lipid responses in human subjects. Br. J. Nutr., 2005, 93, 543-7.
50. Stangl, V.; Dreger, H.; Stangl, K.; Lorenz, M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc. Res., 2007, 73, 348-58.
51. Martin, K.R. Targeting apoptosis with dietary bioactive agents. Exp. Biol. Med., 2006, 231, 117-29.
52. Khan, N.; Afaq, F.; Mukhtar, H. Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis, 2007, 28, 233-9.
53. Mariappan, D.; Winkler, J.; Parthiban, V.; Doss, M.X.; Hescheler, J.; Sachinidis, A. Dietary small molecules and large-scale gene expression studies: An experimental approach for understanding their beneficial effects on the development of malignant and non-malignant proliferative diseases. Curr. Med. Chem., 2006, 13, 1481-9.
54. Syed, D.N.; Khan, N.; Afaq, F.; Mukhtar, H. Chemoprevention of prostate cancer through dietary agents: Progress and promise. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 2193-203.
55. Suganuma, M.; Ohkura, Y.; Okabe, S.; Fujiki, H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol., 2001, 127, 69-72.
56. Ahn, H.Y.; Hadizadeh, K.R.; Seul, C.; Yun, Y.P.; Vetter, H.; Sachinidis, A. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol. Biol. Cell, 1999, 10, 1093-104.
57. Chae, Y.J.; Kim, C.H.; Ha, T.S.; Hescheler, J.; Ahn, H.Y.; Sachinidis, A. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol. Biochem., 2007, 20, 859-66.
58. Nihal, M.; Ahmad, N.; Mukhtar, H.; Wood, G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma. Int. J. Cancer, 2005, 114, 513-21.
59. Afaq, F.; Adhami, V.M.; Ahmad, N.; Mukhtar, H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci., 2002, 7, d784-d792.
60. Witschi, H.; Espiritu, I.; Ly, M.; Uyeminami, D.; Morin, D.; Raabe, O.G. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: A pilot study. Inhal. Toxicol., 2004, 16, 763-70.
61. Deschner, E.E.; Ruperto, J.; Wong, G.; Newmark, H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis, 1991, 12, 1193-6.
62. Mink, P.J.; Scrafford, C.G.; Barraj, L.M.; Harnack, L.; Hong, C.P.; Nettleton, J.A.; Jacobs, D.R., Jr. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am. J. Clin. Nutr., 2007, 85, 895-909.
63. Manach, C.; Morand, C.; Crespy, V.; Demigne, C.; Texier, O.; Regerat, F.; Remesy, C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett., 1998, 426, 331-6.
64. De, S.; Chakraborty, R.N.; Ghosh, S.; Sengupta, A.; Das, S. Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model. J. Exp. Clin. Cancer Res., 2004, 23, 251-8.
65. Volate, S.R.; Davenport, D.M.; Muga, S.J.; Wargovich, M.J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis, 2005, 26, 1450-6.
66. Nair, M.P.; Mahajan, S.; Reynolds, J.L.; Aalinkeel, R.; Nair, H.; Schwartz, S.A.; Kandaswami, C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin. Vaccine Immunol., 2006, 13, 319-28.
67. Graefe, E.U.; Wittig, J.; Mueller, S.; Riethling, A.K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 2001, 41, 492-9.
68. Bhatia, N.; Agarwal, C.; Agarwal, R. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Nutr. Cancer, 2001, 39, 292-9.
69. Cruz-Correa, M.; Shoskes, D.A.; Sanchez, P.; Zhao, R.; Hylind, L.M.; Wexner, S.D.; Giardiello, F.M. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin. Gastroenterol. Hepatol., 2006, 4, 1035-8.
70. Kawanishi, S.; Oikawa, S.; Murata, M. Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox. Signal., 2005, 7, 1728-39.
71. Ciolino, H.P.; Daschner, P.J.; Yeh, G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J., 1999, 340(Pt 3), 715-22.
72. Jin, N.Z.; Zhu, Y.P.; Zhou, J.W.; Mao, L.; Zhao, R.C.; Fang, T.H.; Wang, X.R. Preventive effects of quercetin against benzoapyrene-induced DNA damages and pulmonary precancerous pathologic changes in mice. Basic Clin. Pharmacol. Toxicol., 2006, 98, 593-8.
73. Sharma, H.; Sen, S.; Singh, N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol. Ther., 2005, 4, 949-55.
74. Valerio, L.G., Jr.; Kepa, J.K.; Pickwell, G.V.; Quattrochi, L.C. Induction of human NAD(P)H:qUinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicol. Lett., 2001, 119, 49-57.
75. Cai, Q.; Rahn, R.O.; Zhang, R. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett., 1997, 119, 99-107.
76. Xing, N.; Chen, Y.; Mitchell, S.H.; Young, C.Y. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis, 2001, 22, 409-14.
77. Kim, Y.H.; Lee, Y.J. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J. Cell Biochem., 2007, 100, 998-1009.
78. Balasubramanian, S.; Govindasamy, S. Inhibitory effect of dietary flavonol quercetin on 7, 12-dimethylbenzaanthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis, 1996, 17, 877-9.
79. Kawada, N.; Seki, S.; Inoue, M.; Kuroki, T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 1998, 27, 1265-74.
80. Wei, Y.Q.; Zhao, X.; Kariya, Y.; Fukata, H.; Teshigawara, K.; Uchida, A. Induction of apoptosis by quercetin: Involvement of heat shock protein. Cancer Res., 1994, 54, 4952-7.
81. Ishikawa, Y.; Kitamura, M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int., 2000, 58, 1078-87.
82. Kim, J.H.; Shim, J.S.; Lee, S.K.; Kim, K.W.; Rha, S.Y.; Chung, H.C.; Kwon, H.J. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: Crucial involvement of the down-regulation of matrix metalloproteinase. Jpn. J. Cancer Res., 2002, 93, 1378-85.
83. Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 2007, 28, 1765-73.
84. Tamvakopoulos, C.; Dimas, K.; Sofianos, Z.D.; Hatziantoniou, S.; Han, Z.; Liu, Z.L.; Wyche, J.H.; Pantazis, P. Metabolism an anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin. Cancer Res., 2007, 13, 1269-77.
85. Huang, M.T.; Ma, W.; Lu, Y.P.; Chang, R.L.; Fisher, C.; Manchand, P.S.; Newmark, H.L.; Conney, A.H. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis, 1995, 16, 2493-7.
86. Osawa, T.; Sugiyama, Y.; Inayoshi, M.; Kawakishi, S. Antioxidative activity of tetrahydrocurcuminoids. Biosci. Biotechnol. Biochem., 1995, 59, 1609-12.
87. Sugiyama, Y.; Kawakishi, S.; Osawa, T. Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol., 1996, 52, 519-25.
88. Conney, A.H.; Lou, Y.R.; Xie, J.G.; Osawa, T.; Newmark, H.L.; Liu, Y.; Chang, R.L.; Huang, M.T. Some perspectives on dietary inhibition of carcinogenesis: Studies with curcumin and tea. Proc. Soc. Exp. Biol. Med., 1997, 216, 234-45.
89. Kim, J.M.; Araki, S.; Kim, D.J.; Park, C.B.; Takasuka, N.; Baba-Toriyama, H.; Ota, T.; Nir, Z.; Khachik, F.; Shimidzu, N.; Tanaka, Y.; Osawa, T.; Uraji, T.; Murakoshi, M.; Nishino, H.; Tsuda, H. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation. Carcinogenesis, 1998, 19, 81-5.
90. Furuta, T.; Hirooka, Y.; Abe, A.; Sugata, Y.; Ueda, M.; Murakami, K.; Suzuki, T.; Tanaka, K.; Kan, T. Concise synthesis of dideoxyepigallocatechin gallate (DO-EGCG) and evaluation of its antiinfluenza virus activity. Bioorg. Med. Chem. Lett., 2007, 17, 3095-8.
91. Calias, P.; Galanopoulos, T.; Maxwell, M.; Khayat, A.; Graves, D.; Antoniades, H.N.; d'Alarcao, M. Synthesis of inositol 2-phosphatequercetin conjugates. Carbohydr. Res., 1996, 292, 83-90.
92. Ko, W.C.; Chen, M.C.; Wang, S.H.; Lai, Y.H.; Chen, J.H.; Lin, C.N. 3-O-methylquercetin more selectively inhibits phosphodiesterase subtype 3. Planta Med., 2003, 69, 310-5.
93. Blasiak, J.; Trzeciak, A.; Kowalik, J. Curcumin damages DNA in human gastric mucosa cells and lymphocytes. J. Environ. Pathol. Toxicol. Oncol., 1999, 18, 271-6.
94. VIjayalaxmi. Genetic effects of turmeric and curcumin in mice and rats. Mutat. Res., 1980, 79, 125-32.
95. da Silva, J.; Herrmann, S.M.; Heuser, V.; Peres, W.; Possa, M.N.; Gonzalez-Gallego, J.; Erdtmann, B. Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food Chem. Toxicol., 2002, 40, 941-7.
96. Rastogi, P.B.; Levin, R.E. Induction of sperm abnormalities in mice by quercetin. Environ. Mutagen., 1987, 9, 79-86.
97. Shirai, T.; Sato, A.; Hara, Y. Epigallocatechin gallate. The major causative agent of green tea-induced asthma. Chest, 1994, 106, 1801-5.
98. Stratton, S.P.; Bangert, J.L.; Alberts, D.S.; Dorr, R.T. Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice. Cancer Lett., 2000, 158, 47-52.
99. Goodin, M.G.; Fertuck, K.C.; Zacharewski, T.R.; Rosengren, R.J. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol. Sci., 2002, 69, 354-61.
100. Lotito, S.B.; Frei, B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 2006, 41, 1727-46.
101. Carlson, J.R.; Bauer, B.A.; Vincent, A.; Limburg, P.J.; Wilson, T. Reading the tea leaves: Anticarcinogenic properties of (-)- epigallocatechin-3-gallate. Mayo Clin. Proc., 2007, 82, 725-32.
102. Woodman, O.L.; Chan, E.C. Vascular and anti-oxidant actions of flavonols and flavones. Clin. Exp. Pharmacol. Physiol, 2004, 31, 786-90.
103. Dulak, J. Nutraceuticals as anti-angiogenic agents: Hopes and reality. J. Physiol. Pharmacol., 2005, 56(Suppl 1), 51-67.
104. Jung, C.H.; Lee, J.Y.; Cho, C.H.; Kim, C.J. Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Arch. Pharm. Res., 2007, 30, 1599-607.
105. Tipoe, G.L.; Leung, T.M.; Hung, M.W.; Fung, M.L. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc. Hematol. Disord. Drug Targets, 2007, 7, 135-44.
106. Bischoff, S.C. Quercetin: Potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care, 2008, 11, 733-40.
107. Wolfram, S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr., 2007, 26, 373S-88S.
108. Boots, A.W.; Wilms, L.C.; Swennen, E.L.; Kleinjans, J.C.; Bast, A.; Haenen, G.R. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition, 2008, 24, 703-10.
109. Mao, W.; Song, Y.; Han, C.; Li, N. Molecular mechanism by which green tea and tea extract inhibits left ventricle hypertrophy induced by renovascular hypertension in rats. Wei Sheng Yan. Jiu., 2008, 37, 43-6.
110. Mo, S.F.; Zhou, F.; Lv, Y.Z.; Hu, Q.H.; Zhang, D.M.; Kong, L.D. Hypouricemic action of selected flavonoids in mice: Structure-activity relationships. Biol. Pharm. Bull., 2007, 30, 1551-6.
111. Moon, H.S.; Lee, H.G.; Choi, Y.J.; Kim, T.G.; Cho, C.S. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact., 2007, 167, 85-98.
112. Sagar, S.M.; Yance, D.; Wong, R.K. Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer-Part 2. Curr. Oncol., 2006, 13, 99-107.
113. Miura, Y.; Chiba, T.; Tomita, I.; Koizumi, H.; Miura, S.; Umegaki, K.; Hara, Y.; Ikeda, M.; Tomita, T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr., 2001, 131, 27-32.
114. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 2007, 18, 427-42.
115. L'Allemain, G. Multiple actions of EGCG, the main component of green tea. Bull. Cancer, 1999, 86, 721-4.
116. Ramana, B.V.; Raju, T.N.; Kumar, V.V.; Reddy, P.U. Defensive role of quercetin against imbalances of calcium, sodium, and potassium in galactosemic cataract. Biol. Trace Elem. Res., 2007, 119, 35-41.
117. Shankar, S.; Ganapathy, S.; Srivastava, R.K. Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci., 2007, 12, 4881-99.
118. Yang, J.H.; Hsia, T.C.; Kuo, H.M.; Chao, P.D.; Chou, C.C.; Wei, Y.H.; Chung, J.G. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos., 2006, 34, 296-304.
119. Sukhthankar, M.; Yamaguchi, K.; Lee, S.H.; McEntee, M.F.; Eling, T.E.; Hara, Y.; Baek, S.J. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology, 2008, 134, 1972-80.
120. Albrecht, D.S.; Clubbs, E.A.; Ferruzzi, M.; Bomser, J.A. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem. Biol. Interact., 2008, 171, 89-95.
121. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 2003, 23, 363-98.
122. Hayakawa, S.; Saeki, K.; Sazuka, M.; Suzuki, Y.; Shoji, Y.; Ohta, T.; Kaji, K.; Yuo, A.; Isemura, M. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem. Biophys. Res. Commun., 2001, 285, 1102-6.
123. Beniston, R.G.; Morgan, I.M.; O'Brien, V.; Campo, M.S. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. Carcinogenesis, 2001, 22, 1069-76.
124. Kandil, F.E.; Smith, M.A.; Rogers, R.B.; Pepin, M.F.; Song, L.L.; Pezzuto, J.M.; Seigler, D.S. Composition of a chemopreventive proanthocyanidin-rich fraction from cranberry fruits responsible for the inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity. J. Agric. Food Chem., 2002, 50, 1063-9.